A detailed history of Sittner & Nelson, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sittner & Nelson, LLC holds 598 shares of VRTX stock, worth $300,465. This represents 0.13% of its overall portfolio holdings.

Number of Shares
598
Previous 598 -0.0%
Holding current value
$300,465
Previous $280,000 0.71%
% of portfolio
0.13%
Previous 0.14%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$343.0 - $410.68 $102,900 - $123,204
300 Added 100.67%
598 $243,000
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $20,290 - $21,747
60 Added 25.21%
298 $103,000
Q1 2023

May 09, 2023

BUY
$283.23 - $323.1 $32,004 - $36,510
113 Added 90.4%
238 $74,000
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $16,155 - $18,026
-59 Reduced 32.07%
125 $36,000
Q2 2022

Aug 12, 2022

BUY
$234.96 - $292.55 $13,862 - $17,260
59 Added 47.2%
184 $52,000
Q1 2022

May 10, 2022

BUY
$221.42 - $260.97 $11,071 - $13,048
50 Added 66.67%
125 $33,000
Q4 2021

Feb 09, 2022

SELL
$177.01 - $223.45 $4,425 - $5,586
-25 Reduced 25.0%
75 $16,000
Q2 2021

Aug 12, 2021

BUY
$187.49 - $221.1 $18,749 - $22,110
100 New
100 $20,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sittner & Nelson, LLC Portfolio

Follow Sittner & Nelson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sittner & Nelson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sittner & Nelson, LLC with notifications on news.